Walleye Capital’s PetMed Express PETS Stock Holding History

Walleye Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-62,348	Closed	-$253K	–	5733
2024 Q2	$253K	Sell	62,348 -84,039	-57%	-$359K	﹤0.01%	4122
2024 Q1	$701K	Buy	146,387 +21,743	+17%	+$126K	﹤0.01%	2906
2023 Q4	$942K	Buy	124,644 +95,873	+333%	+$787K	﹤0.01%	2397
2023 Q3	$295K	Buy	28,771 +11,383	+65%	+$140K	﹤0.01%	3247
2023 Q2	$240K	Sell	17,388 -25,623	-60%	-$385K	﹤0.01%	2972
2023 Q1	$698K	Buy	+43,011	New	+$810K	0.01%	1419
2022 Q4	–	Sell	-17,279	Closed	-$337K	–	3522
2022 Q3	$337K	Buy	+17,279	New	+$367K	0.01%	1752
2019 Q4	–	Sell	-5,100	Closed	-$114K	–	2149
2019 Q3	$92K	Sell	5,100 -8,500	-63%	-$140K	0.01%	1455
2019 Q2	$213K	Buy	+13,600	New	+$268K	0.02%	930

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return

Walleye Capital's PETS Position: Q3 2024 in Review

Walleye Capital sold out of PetMed Express (PETS) in Q3 2024, closing a stake of 62,348 shares — an estimated $253K sold.

Walleye Capital first reported a position in PETS in Q2 2019 and held it in 9 quarters. The position peaked at $942K in Q4 2023. 93 funds tracked by Wall St. Rank hold PETS as of Q3 2024.

Walleye Capital reported no remaining PetMed Express position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 62,348 PetMed Express shares in Q3 2024, an estimated $253K.
Walleye Capital first reported a position in PetMed Express in Q2 2019 and held it in 9 quarters.
Walleye Capital's PetMed Express position peaked at $942K in Q4 2023.
93 funds tracked by Wall St. Rank held PetMed Express as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.